Skip to main content
Health Tech
- Monday, 10th February 14:05 - 14:25

Building Predictive Diagnostic Models for Women's Reproductive Health: Using Data and AI to Improve Outcomes

Hertility is a revolutionary approach to preventative and personalised medicine across women's reproductive health. With the largest global dataset of female gynaecological health, Hertility have leveraged this extensive dataset to build predictive algorithms for the most prevalent conditions affecting fertility and reproductive health. Providing next-generation diagnostic testing, telemedicine, treatments and prescriptions for women from menstruation through menopause. Hertility’s diagnostic testing and clinical services provide advanced insights into reproductive health, fertility decline, and the onset of menopause as well as the diagnosis of 18 conditions. Hertility reduces diagnosis times for some conditions from nine years to nine days. Hertility’s clinical trials aim to raise the standard of scientific rigour and education in female health to radically reduce time to diagnosis and fast-track women to specialist care sooner. They’re calling this the Reproductive Revolution.


Speakers

item.entity.field_swapcard_image.entity.field_media_image.entity.alt
Dr. Helen O'Neill
Founder & CEO
Hertility Health